• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Surgical Endoscopy >Predictive factors for extraction of common bile duct stones during endoscopic retrograde cholangiopancreatography in Billroth II anatomy patients
【24h】

Predictive factors for extraction of common bile duct stones during endoscopic retrograde cholangiopancreatography in Billroth II anatomy patients

机译：白镜逆行胆管胆囊术中普通胆管结石提取的预测因素百思植物分解患者

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background Endoscopic retrograde cholangiopancreatography (ERCP) for extraction of common bile duct (CBD) stones in Billroth II anatomy patients is still a technical challenge and factors affecting stone extraction have not yet been clarified. This study aimed to analyze our experience and evaluate potential factors affecting CBD stone extraction. Methods A retrospective analysis of CBD stones patients with a history of Billroth II gastrectomy, who underwent therapeutic ERCP for stone extraction at our center from August 1999 to December 2017, was conducted. The outcomes of ERCP and potential factors affecting stone extraction were examined. Results A total of 227 patients were enrolled, and 176 patients (77.5%) achieved technical success. The success rate of duodenal ampullary access and selective biliary cannulation was 84.1% (191/227) and 92.1% (176/191), respectively. The mean CBD diameter was 15 mm (range 6-35 mm), and the largest stone size was 13 mm (range 4-36 mm). CBD stones were ultimately removed in 137 patients (77.8%), and 105 patients (59.7%) for the first session. Mechanical lithotripsy was used in 17 patients (9.7%). The overall ERCP-related complication rate was 6.3% (11/176), including bleeding in 3 patients (1.7%) and mild pancreatitis in 6 patients (3.4%). The multivariate analysis indicated that CBD stone number >= 2 (OR 2.171; 95% CI 1.095-4.306; p = 0.027), and the largest CBD stone size >= 12 mm (OR 3.646; 95% CI 1.833-7.251; p < 0.001) were patient-related risk factors for failed stone removal; while the use of endoscopic papillary (large) balloon dilation (EPBD/EPLBD) (OR 0.291; 95% CI 0.147-0.576; p < 0.001) was a procedure-related protective factor for successful stone extraction. Conclusions ERCP is safe and effective for extraction of CBD stones in Billroth II anatomy patients. The number and the largest size of CBD stones, and the use of EPBD/EPLBD are predictive factors for CBD stone extraction.
机译：背景技术内窥镜逆行胆管胰胆管造影（ERCP）用于提取普通胆管（CBD）石块在Billroth II解剖患者中仍然是影响石油提取的技术挑战，尚未澄清。本研究旨在分析我们的经验和评估影响CBD石提取的潜在因素。方法采用2019年8月至2017年8月，在我们的中心接受了钙水II胃切除术历史衰减患者患有历史的CBD石头患者的回顾性分析。检查了影响石油提取的ERCP和潜在因素的结果。结果共有227名患者，176名患者（77.5％）取得了技术成功。十二指肠大部分腹盆和选择性胆汁插管的成功率分别为84.1％（191/227）和92.1％（176/191）。平均CBD直径为15毫米（范围6-35mm），最大的石材尺寸为13毫米（范围为4-36毫米）。最终在137名患者（77.8％）和105名患者（59.7％）中最终移除了CBD石头。 17名患者使用机械碎石术（9.7％）。整体ERCP相关的并发症率为6.3％（11/176），包括3名患者出血（1.7％）和6名患者的轻度胰腺炎（3.4％）。多变量分析表明，CBD石数> = 2（或2.171; 95％CI 1.095-4.306; P = 0.027），最大的CBD石材尺寸> = 12 mm（或3.646; 95％CI 1.83-7.251; P < 0.001）患者有关的患者危险因素，用于石头去除失败;而使用内镜乳头状（大）球囊扩张（EPBD / EPLBD）（或0.291; 95％CI 0.147-0.576; P <0.001）是一种成功的石头提取的程序相关的保护因素。结论ERCP在Billroth II解剖患者中提取CBD石块是安全可有效的。 CBD石头的数量和最大尺寸，以及EPBD / EPLBD的使用是CBD石提取的预测因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号